April 27, 2022 PAO-04-22-R250-73
In another interview from the Road to 50 States trip, Sam Jeffrey, Vice President of General Toxicology and Archiving Services at StageBio, talks to Nigel about StageBio’s broad range of service offerings after acquiring a number of new companies.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries.
StageBio's integrated offering includes tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to regulatory approval, detailed pathology reporting for GLP studies, medical device pathology, immunohistochemistry, and neuropathology.